Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price ↑
A02AC10	RENNIE	B	Magnesium carbonate - 80mg, Calcium carbonate - 680mg		Tablet, chewable	240,548 L.L
A02BC01	RISEK	G	Omeprazole - 20mg	20mg	Capsule, enteric coated	302,365 L.L
A02BC01	RISEK	G	Omeprazole - 40mg	40mg	Capsule, enteric coated	522,755 L.L
A02BC01	RISEK	G	Omeprazole (sodium) - 40mg	40mg	Injectable lyophilised powder for solution	592,635 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	727,019 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,252,461 L.L
A02BC02	RAZON 20	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	747,176 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 10mg	10mg	Tablet, film coated	212,327 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, film coated	212,327 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
A02BC04	RAMEP	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	518,809 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
A03CB01	RESTROPINAL PEDIATRIC	B	Butobarbital - 2mg/ml, Methyl hyoscine nitrate - 0.1mg/ml		Drops	197,097 L.L
A06AX05	RESOLOR	B	Prucalopride succinate - 2mg	2mg	Tablet, film coated	5,251,736 L.L
A06AX05	RESOLOR	B	Prucalopride succinate - 1mg	1mg	Tablet, film coated	3,273,600 L.L
A07XA04	RACECADOTRIL ARROW	G	Racecadotril - 100mg	100mg	Capsule	583,228 L.L
A07XA04	RACECADOTRIL BGR	G	Racecadotril - 100mg	100mg	Capsule	575,165 L.L
A07XA04	RACECADOTRIL BIOGARAN CONSEIL	G	Racecadotril - 100mg	100mg	Capsule	287,582 L.L
A10AD06	RYZODEG	BioTech	Insulin degludec - 70%, Insulin aspart - 30%	100IU/ml	Injectable solution	7,058,661 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 2mg	2mg	Tablet	831,839 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 0.5mg	0.5mg	Tablet	831,839 L.L
A10BX02	REPAGLINIDE ARROW LAB	G	Repaglinide - 1mg	1mg	Tablet	831,839 L.L
A11GA01	REDOXON EFF.ORANGE	B	Ascorbic acid (vit C) - 1g	1g	Tablet, effervescent	366,869 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 2.5mg	2.5mg	Tablet, film coated	3,199,625 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 15	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,164,664 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 20	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,164,664 L.L

...